Skip to main content

Table 7 Comparison according to tumor recurrence among HCC group regarding baseline laboratory results

From: Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment

Variables

Recurrence (N = 5)

Remission (N = 25)

^P value

Hemoglobin (g/dL)

10.3 ± 1.0

12.4 ± 1.5

0.007*

TLC (× 103/mL)

6.4 ± 2.3

6.8 ± 1.9

0.664

Platelets (× 103/mL)

185.6 ± 24.4

170.8 ± 40.5

0.440

AST (IU/L)

44.2 ± 31.2

52.2 ± 28.2

0.572

ALT (IU/L)

85.0 ± 47.4

55.6 ± 27.4

0.063

Albumin (g/dL)

3.3 ± 0.2

3.7 ± 0.4

0.006*

Total bilirubin (mg/dL)

1.4 ± 0.6

1.3 ± 0.5

0.525

Direct bilirubin (mg/dL)

0.7 ± 0.2

0.6 ± 0.3

0.295

Alkaline Ph. (mg/dL)

72.0 ± 21.5

77.5 ± 26.0

0.663

INR

1.5 ± 0.5

1.2 ± 0.4

0.135

Creatinine (mg/dL)

1.00 ± 0.37

0.80 ± 0.34

0.261

  1. ^Independent t test
  2. *Significant